• CardioExcyte 96

    Combined impedance and MEA-like recordings
  • CardioExcyte 96

    For cardiac safety screening
  • CardioExcyte 96

    Next generation label-free cell analysis
  • CardioExcyte 96

    Intuitive data analysis & arrhythmia detection
  • CardioExcyte 96

    Transparent plates available for imaging

2017 - Cross-site comparison of myocyte phase II compounds on different iPS cardiomyocytes based on CardioExcyte 96 recordings

Icon CE   CardioExcyte 96 presentation (slide deck)   logo pdf   (2.2 MB)

Presenter:
Dr. Corina Bot, Nanion Technologies, Inc.

Source:
CiPA Cardiac stem cell working group webinar
September 20. 2017

Back to Overview

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok